- The report contains detailed information about Diabetex International Corp. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
- Another part of the report is a SWOT-analysis carried out for Diabetex International Corp.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
- The Diabetex International Corp. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
- In the part that describes Diabetex International Corp. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
- Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Diabetex International Corp. business.
About Diabetex International Corp.
Diabetex International Corporation (Diabetex or the Company) focuses on diabetes-related products and services. The Company is considered a development stage company. The Company is presently involved in the treatment of the disease of diabetes.
In June 1999, Diabetex acquired the rights to a treatment program called Metabolic Activation for the treatment of metabolic diseases. This treatment program was the property of Advanced Metabolic Systems, a Delaware corporation (AMSys). In order to provide an avenue for the Company to acquire the rights to Metabolic Activation, AMSys spun a new corporation, Advanced Metabolic Technologies, Inc. (AMTech). All of the assets held by AMSys associated with metabolic disorders became the assets of AMTech. Diabetex, in turn, acquired 100% of this new company. AMTech is a wholly owned subsidiary of Diabetex International Corporation. This acquisition combined two complimentary technologies, diabetes metering systems with diabetes treatment technology.
In June 1999, the Company acquired an exclusive license from Hamilton-May Corporation (Hamilton-May) for an insulin infusion pumping system. Hamilton-May is awaiting patents for this device, which has been named the "Fluid Micrometer". This new technology is intended to deliver metabolic disorder treatment as well as Continuous Subcutaneous Insulin Infusion (CSII) for individuals with diabetes while measuring glucose levels.
Principal Products and Services
Diabetex Non-Invasive Glucose Measurement Device:
The Company holds an exclusive worldwide license to manufacture, develop and market a non-invasive patented device for the measurement of blood glucose, glycosolated hemoglobin A1C (average blood glucose level measurement), and other blood levels to help treat diabetes and other diseases. Prototypes have been developed and there has been clinical testing for the purpose of refinement, but no request for approval from the Food and Drug Administration (FDA) has as of yet been requested.
Metabolic Activation Treatment
Through the acquisition of AmTech, the Company has the exclusive license to market a patented metabolic treatment known as Metabolic Activation. Current medical publications also refer to this treatment as Hepatic Activation or Chronic Intermittent Intensive Insulin Therapy (CIIIT). This treatment is delivered via a special intravenous infusion device, or pump, with the desired pattern of infusion pre-programmed into the pump. The pump is currently used is the Bionica Microdose Pump.
Training of Metabolic Activation Technicians
The Company, through its acquisition of AmTech, acquired all of the Clinic Operations Manuals, Training Manuals and the services of all training personnel used to oversee the establishment of Metabolic Activation Clinics. The Company currently supplies all services and training required for these and new clinics by providing technical assistance to hospitals, doctors and support staff
Diabetex International Corporation was founded in 1983.
The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.
1. DIABETEX INTERNATIONAL CORP. COMPANY PROFILE
1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History
2. DIABETEX INTERNATIONAL CORP. BUSINESS OVERVIEW
2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units
3. DIABETEX INTERNATIONAL CORP. SWOT ANALYSIS
4. DIABETEX INTERNATIONAL CORP. FINANCIAL ANALYSIS
4.1. Financial Statements
4.1.1. Income Statement
4.1.2. Balance Sheet
4.1.3. Cash Flow
4.2. Financial Ratios
4.2.2. Margin Analysis
4.2.3. Asset Turnover
4.2.4. Credit Ratios
4.2.5. Long-Term Solvency
4.2.6. Growth Over Prior Year
4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot
5. DIABETEX INTERNATIONAL CORP. COMPETITORS AND INDUSTRY ANALYSIS
5.1. Diabetex International Corp. Direct Competitors
5.2. Comparison of Diabetex International Corp. and Direct Competitors Financial Ratios
5.3. Comparison of Diabetex International Corp. and Direct Competitors Stock Charts
5.4. Diabetex International Corp. Industry Analysis
5.4.1. Healthcare Services Industry Snapshot
5.4.2. Diabetex International Corp. Industry Position Analysis
6. DIABETEX INTERNATIONAL CORP. NEWS & EVENTS
6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events
7. DIABETEX INTERNATIONAL CORP. EXPERTS REVIEW1
7.1. Experts Opinion
7.2. Experts Estimates
8. DIABETEX INTERNATIONAL CORP. ENHANCED SWOT ANALYSIS2
9. UNITED STATES PESTEL ANALYSIS2
9.1. Political Factors
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors
10. DIABETEX INTERNATIONAL CORP. IFE, EFE, IE MATRICES2
10.1. Internal Factor Evaluation Matrix
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix
11. DIABETEX INTERNATIONAL CORP. PORTER FIVE FORCES ANALYSIS2
12. DIABETEX INTERNATIONAL CORP. VRIO ANALYSIS2
APPENDIX: RATIO DEFINITIONS
LIST OF TABLES
Diabetex International Corp. Key Facts
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Diabetex International Corp. Key Executives
Key Executives Biographies1
Key Executives Compensations1
Diabetex International Corp. Major Shareholders
Diabetex International Corp. History
Diabetex International Corp. Products
Revenues by Segment
Revenues by Region
Diabetex International Corp. Offices and Representations
Diabetex International Corp. SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
Diabetex International Corp. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Diabetex International Corp. Capital Market Snapshot
Diabetex International Corp. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Healthcare Services Industry Statistics
Diabetex International Corp. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Diabetex International Corp. Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Revenue Estimates Trend1
Earnings Estimates Trend1
LIST OF FIGURES
Diabetex International Corp. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Diabetex International Corp. 1-year Stock Charts
Diabetex International Corp. 5-year Stock Charts
Diabetex International Corp. vs. Main Indexes 1-year Stock Chart
Diabetex International Corp. vs. Direct Competitors 1-year Stock Charts
Diabetex International Corp. Article Density Chart
1 – Data availability depends on company’s security policy.
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.
Enhanced SWOT Analysis
Enhanced SWOT is a 3×3 grid that arranges strengths, weaknesses, opportunities and threats into one scheme:
- How to use the strengths to take advantage of the opportunities?
- How to use the strengths to reduce likelihood and impact of the threats?
- How to overcome the weaknesses that obstruct taking advantage of the opportunities?
- How to overcome the weaknesses that can make the threats a reality?
Upon answering these questions a company can develop a project plan to improve its business performance.
PESTEL (also termed as PESTLE) is an ideal tool to strategically analyze what influence different outside factors – political, economic, sociocultural, technological, environmental and legal – exert on a business to later chart its long term targets.
Being part of the external analysis when carrying out a strategic assessment or performing a market study, PESTEL gives an overview of diverse macro-environmental factors that any company should thoughtfully consider. By perceiving these outside environments, businesses can maximally benefit from the opportunities while minimizing the threats to the organization.
Key Factors Examined by PESTEL Analysis:
- Political – What opportunities and pressures are brought by political bodies and what is the degree of public regulations’ impact on the business?
- Economic – What economic policies, trends and structures are expected to affect the organization, what is this influence’s degree?
- Sociological – What cultural and societal aspects will work upon the demand for the business’s products and operations?
- Technological – What impact do the technological aspects, innovations, incentives and barriers have on the organization?
- Environmental – What environmental and ecological facets, both locally and farther afield, are likely to predetermine the business?
- Legal – What laws and legislation will exert influence on the style the business is carried out?
IFE, EFE, IE Matrices
The Internal Factor Evaluation matrix (IFE matrix) is a strategic management tool helping audit or evaluate major weaknesses and strengths in a business’s functional areas. In addition, IFE matrix serves as a basis for identifying and assessing relationships amongst those areas. The IFE matrix is utilised in strategy formulation.
The External Factor Evaluation matrix (EFE matrix) is a tool of strategic management that is typically utilised to assess current market conditions. It is an ideal instrument for visualising and prioritising the threats and opportunities a firm is facing.
The essential difference between the above mentioned matrices lies in the type of factors incorporated in the model; whilst the latter is engaged in internal factors, the former deals exceptionally with external factors – those exposed to social, political, economic, legal, etc. external forces.
Being a continuation of the EFE matrix and IFE matrix models, the Internal External matrix (IE matrix) rests upon an investigation of external and internal business factors integrated into one suggestive model.
Porter Five Forces Analysis
The Porter’s five forces analysis studies the industry of operation and helps the company find new sources of competitive advantage. The analysis surveys an industry through five major questions:
- What composes a threat of substitute products and services?
- Is there a threat of new competitors entering the market?
- What is the intensity of competitive rivalry?
- How big is the bargaining power of buyers?
- How significant is the bargaining power of suppliers?
VRIO stands for Value, Rarity, Imitability, Organization. This analysis helps to evaluate all company’s resources and capabilities and bring them together into one aggregate table that includes:
- Tangible resources
- Intangible resources
- Innovation and Creativity
- Organizational capabilities
The result of the analysis gives a clear picture of company’s competitive and economic implications, answering the questions if the resources mentioned above are:
- Costly to imitate?
- Organized properly?